Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lisinopril"" wg kryterium: Temat


Tytuł:
Closing the gap - development of an analytical methodology using volumetric absorptive microsampling of finger prick blood followed by LC-HRMS/MS for adherence monitoring of antihypertensive drugs.
Autorzy:
Jacobs CM; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
Kunz M; Klinik für Innere Medizin III (Kardiologie, Angiologie und Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.
Mahfoud F; Klinik für Innere Medizin III (Kardiologie, Angiologie und Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.; Institute for Medical Engineering and Science, MIT, Cambridge, MA, USA.
Wagmann L; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
Meyer MR; Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany. .
Pokaż więcej
Źródło:
Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2023 Jan; Vol. 415 (1), pp. 167-177. Date of Electronic Publication: 2022 Nov 01.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*
Lisinopril*
Tandem Mass Spectrometry/methods ; Chromatography, Liquid/methods ; Blood Specimen Collection/methods ; Angiotensin-Converting Enzyme Inhibitors ; Medication Adherence ; Dried Blood Spot Testing/methods
Czasopismo naukowe
Tytuł:
Lisinopril-Induced Small Bowel Angioedema: An Unusual Cause of Severe Abdominal Pain.
Autorzy:
Johnson BW; Department of Anesthesiology, Mayo Clinic, Phoenix, AZ, USA.
Rydburg AM; Medical Student, Mayo Clinic Alix School of Medicine, Phoenix, AZ, USA.
Do VD; Department of Hospital Internal Medicine, Mayo Clinic, Phoenix, AZ, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2022 Nov 22; Vol. 23, pp. e937895. Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lisinopril*/adverse effects
Angioedema*/chemically induced
Angioedema*/diagnosis
Female ; Humans ; Middle Aged ; Abdominal Pain/chemically induced ; Abdominal Pain/diagnosis ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Abdomen
Czasopismo naukowe
Tytuł:
Angiotensin-Converting Enzyme Inhibitor "Lisinopril" Antagonizes Hepatic TGF-β1, improving Hepatic Fibrosis Caused by Experimental Schistosomiasis mansoni.
Autorzy:
Mostafa, Reham R.
Elarousy, Maha H.
Shalaby, Maisa A.
Abdelaal, Amany A.
Mahmoud, Soheir S.
Badawi, Manal A.
Ismail, Sherif M.
Nahnoush, Reham K.
Pokaż więcej
Źródło:
Egyptian Academic Journal of Biological Sciences E Medical Entomology & Parasitology. 2023, Vol. 15 Issue 1, p45-59. 15p.
Czasopismo naukowe
Tytuł:
Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers.
Autorzy:
Misaka S; Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Ono Y; Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Uchida A; Department of Pharmacy, University of Yamanashi Hospital, Chuo-city, Japan.
Ono T; Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Abe O; Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Ogata H; Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Sato H; Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Japan.
Suzuki M; Department of Pharmacy, University of Yamanashi Hospital, Chuo-city, Japan.
Onoue S; Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Japan.
Shikama Y; Center for Medical Education and Career Development, Fukushima Medical University, Fukushima, Japan.
Shimomura K; Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2021 Mar; Vol. 14 (2), pp. 476-480. Date of Electronic Publication: 2020 Oct 22.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Food-Drug Interactions*
Catechin/*analogs & derivatives
Lisinopril/*pharmacokinetics
Tea/*chemistry
Administration, Oral ; Adult ; Catechin/administration & dosage ; Catechin/pharmacokinetics ; Cross-Over Studies ; Fasting ; Female ; Healthy Volunteers ; Humans ; Intestinal Absorption ; Lisinopril/administration & dosage ; Male ; Young Adult
Czasopismo naukowe
Tytuł:
Population pharmacokinetics of lisinopril in hypertensive children and adolescents with normal to mildly reduced kidney function.
Autorzy:
Sandra, Louis (AUTHOR)
Degraeuwe, Eva (AUTHOR)
De Bruyne, Pauline (AUTHOR)
De Baere, Siegrid (AUTHOR)
Croubels, Siska (AUTHOR)
Van Bocxlaer, Jan F. P. (AUTHOR)
Raes, Ann (AUTHOR)
Vande Walle, Johan (AUTHOR)
Gasthuys, Elke (AUTHOR)
Vermeulen, An (AUTHOR)
Pokaż więcej
Źródło:
British Journal of Clinical Pharmacology. Feb2024, Vol. 90 Issue 2, p504-515. 12p.
Czasopismo naukowe
Tytuł:
Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.
Autorzy:
Derington CG; Department of Population Health Sciences, School of Medicine, University of Utah, Salt Lake City, UT, United States of America.
King JB; Department of Population Health Sciences, School of Medicine, University of Utah, Salt Lake City, UT, United States of America.; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, United States of America.
Delate T; University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, United States of America.; Drug Use Management, Kaiser Permanente National Pharmacy, Aurora, CO, United States of America.
Botts SR; Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO, United States of America.
Kroehl M; Colorado School of Public Health, Aurora, CO, United States of America.
Kao DP; Cardiac and Vascular Center, University of Colorado Health, Aurora, CO, United States of America.; School of Medicine, University of Colorado, Aurora, CO, United States of America.
Trinkley KE; University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, United States of America.; School of Medicine, University of Colorado, Aurora, CO, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Dec 03; Vol. 15 (12), pp. e0243371. Date of Electronic Publication: 2020 Dec 03 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Angioedema/*epidemiology
Antihypertensive Agents/*administration & dosage
Hypertension/*drug therapy
Lisinopril/*administration & dosage
Losartan/*administration & dosage
Aged ; Aged, 80 and over ; Angioedema/chemically induced ; Antihypertensive Agents/adverse effects ; Blood Pressure/drug effects ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Humans ; Hypertension/diagnosis ; Lisinopril/adverse effects ; Losartan/adverse effects ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Homoarginine treatment of rats improves cardiac function and remodeling in response to pressure overload.
Autorzy:
Koch V; Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Cardiology, Angiology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
Gruenewald LD; Goethe University Frankfurt, Frankfurt am Main, Germany.
Gruber-Rouh T; Goethe University Frankfurt, Frankfurt am Main, Germany.
Martin S; Goethe University Frankfurt, Frankfurt am Main, Germany.
Eichler K; Goethe University Frankfurt, Frankfurt am Main, Germany.
Booz C; Goethe University Frankfurt, Frankfurt am Main, Germany.
Yel I; Goethe University Frankfurt, Frankfurt am Main, Germany.
Vogl TJ; Goethe University Frankfurt, Frankfurt am Main, Germany.
Buchner K; Institute of Human Genetics, Section for Developmental Genetics, University of Heidelberg, Heidelberg, Germany.
Hagenmueller M; Department of Cardiology, Angiology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
März W; Synlab Academy, Synlab Holding Deutschland GmbH, Augsburg, Germany.
Frey N; Department of Cardiology, Angiology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
Hardt SE; Department of Cardiology, Angiology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
Riffel JH; Department of Cardiology, Angiology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
Pokaż więcej
Źródło:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2022 Dec; Vol. 36 (6), pp. 992-1004. Date of Electronic Publication: 2022 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*/drug therapy
Heart Failure*/drug therapy
Rats ; Male ; Animals ; NG-Nitroarginine Methyl Ester/pharmacology ; Spironolactone/metabolism ; Spironolactone/pharmacology ; Spironolactone/therapeutic use ; Homoarginine/metabolism ; Homoarginine/pharmacology ; Homoarginine/therapeutic use ; Lisinopril/metabolism ; Lisinopril/pharmacology ; Lisinopril/therapeutic use ; Ventricular Remodeling ; Rats, Wistar ; Myocardium/metabolism ; Blood Pressure
Czasopismo naukowe
Tytuł:
Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice.
Autorzy:
Kakutani N; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.; Japan Society for the Promotion of Science, Tokyo, Japan.
Takada S; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan. .; Faculty of Lifelong Sport, Department of Sports Education, Hokusho University, Ebetsu, Japan. .
Nambu H; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Matsumoto J; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Furihata T; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Yokota T; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Fukushima A; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Kinugawa S; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Pokaż więcej
Źródło:
Skeletal muscle [Skelet Muscle] 2020 Apr 25; Vol. 10 (1), pp. 11. Date of Electronic Publication: 2020 Apr 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Lisinopril/*therapeutic use
Muscle, Skeletal/*pathology
Muscular Diseases/*drug therapy
Myocardial Infarction/*complications
Angiotensin II/blood ; Angiotensin-Converting Enzyme Inhibitors/administration & dosage ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Animals ; Collagen/genetics ; Collagen/metabolism ; Fibrosis ; Lisinopril/administration & dosage ; Lisinopril/pharmacology ; Male ; Mice ; Mice, Inbred C57BL ; Muscle, Skeletal/drug effects ; Muscle, Skeletal/metabolism ; Muscular Diseases/etiology ; Muscular Diseases/pathology ; Smad Proteins/genetics ; Smad Proteins/metabolism ; Transforming Growth Factor beta/genetics ; Transforming Growth Factor beta/metabolism
Czasopismo naukowe
Tytuł:
Predicting response to lisinopril in treating hypertension: a pilot study.
Autorzy:
Sonn BJ; Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA.; Center for Bioinformatics & Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA.; Skaggs School of Pharmacy, University of Colorado, Aurora, CO, USA.
Saben JL; Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA. .; Emergency Department, University of Colorado - Anschutz Medical Campus, Building 400, Q09-127,12469 E 17th Pl, 80045, Aurora, CO, USA. .
McWilliams G; Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA.
Shelton SK; Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA.
Flaten HK; Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA.
D'Alessandro A; Department of Structural Biology and Biochemistry, Metabolomics Core, University of Colorado Anschutz Campus, Aurora, CO, USA.
Monte AA; Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA.; Center for Bioinformatics & Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA.; Skaggs School of Pharmacy, University of Colorado, Aurora, CO, USA.; Rocky Mountain Poison & Drug Center, Denver Health and Hospital Authority, Denver, CO, USA.
Pokaż więcej
Źródło:
Metabolomics : Official journal of the Metabolomic Society [Metabolomics] 2019 Oct 03; Vol. 15 (10), pp. 133. Date of Electronic Publication: 2019 Oct 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antihypertensive Agents/*pharmacology
Hypertension/*drug therapy
Lisinopril/*pharmacology
Antihypertensive Agents/blood ; Antihypertensive Agents/metabolism ; Biomarkers/blood ; Biomarkers/metabolism ; Blood Pressure/drug effects ; Humans ; Hypertension/blood ; Hypertension/metabolism ; Lisinopril/blood ; Lisinopril/metabolism ; Mass Spectrometry ; Metabolomics ; Pilot Projects ; Regression Analysis
Czasopismo naukowe
Tytuł:
Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).
Autorzy:
Shima Y; Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.
Nakanishi K; Department of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, 207 Uehara Nishihara-Cho, Nakagami-Gun, Okinawa, 903-0125, Japan. .
Sako M; Division of Clinical Trials, Department of Clinical Research Promotion, Clinical Research Center, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan.
Saito-Oba M; Department of Medical Statistics Faculty of Medicine, Toho University, Ota-Ku, Tokyo, Japan.
Hamasaki Y; Department of Pediatric Nephrology, Faculty of Medicine, Toho University, Ota-Ku, Tokyo, Japan.
Hataya H; Department of General Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan.
Honda M; Department of Nephrology, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan.
Kamei K; Department of Nephrology and Rheumatology, National Center for Child Health and Development, Setagaya-Ku, Tokyo, Japan.
Ishikura K; Department of Nephrology and Rheumatology, National Center for Child Health and Development, Setagaya-Ku, Tokyo, Japan.
Ito S; Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan.
Kaito H; Department of Nephrology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
Tanaka R; Department of Nephrology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
Nozu K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Nakamura H; Clinical Research Center, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Bunkyo-Ku, Tokyo, Japan.
Iijima K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Yoshikawa N; Clinical Research Center, Wakayama Medical University, Wakayama, Japan.
Pokaż więcej
Corporate Authors:
Japanese Study Group of Kidney Disease in Children (JSKDC)
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2019 May; Vol. 34 (5), pp. 837-846. Date of Electronic Publication: 2018 Oct 03.
Typ publikacji:
Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Glomerulonephritis, IGA/*drug therapy
Lisinopril/*administration & dosage
Losartan/*administration & dosage
Proteinuria/*drug therapy
Adolescent ; Child ; Child, Preschool ; Drug Therapy, Combination/adverse effects ; Drug Therapy, Combination/methods ; Female ; Glomerulonephritis, IGA/complications ; Glomerulonephritis, IGA/diagnosis ; Glomerulonephritis, IGA/pathology ; Humans ; Kidney Glomerulus/pathology ; Lisinopril/adverse effects ; Losartan/adverse effects ; Male ; Prospective Studies ; Proteinuria/diagnosis ; Proteinuria/etiology ; Proteinuria/urine ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Persea americana seed extract restores defective sperm quality and biochemical parameters relevant to reproduction in male wistar rats treated with cyclosporine A.
Autorzy:
Adebayo AA; Chemical Sciences Department (Biochemistry Option), Joseph Ayo Babalola University, Ikeji Arakeji, Nigeria.
Babatola LJ; Chemical Sciences Department (Biochemistry Option), Joseph Ayo Babalola University, Ikeji Arakeji, Nigeria.
Fasanya CB; Chemical Sciences Department (Biochemistry Option), Joseph Ayo Babalola University, Ikeji Arakeji, Nigeria.
Oboh G; Biochemistry Department, Federal University of Technology, Akure, Nigeria.
Pokaż więcej
Źródło:
Journal of food biochemistry [J Food Biochem] 2022 Nov; Vol. 46 (11), pp. e14220. Date of Electronic Publication: 2022 May 13.
Typ publikacji:
Journal Article
MeSH Terms:
Infertility*/drug therapy
Persea*/chemistry
Plant Extracts*/pharmacology
Animals ; Male ; Rats ; Antioxidants/metabolism ; Arginase ; Cyclosporine/pharmacology ; Lisinopril/pharmacology ; Rats, Wistar ; Reproduction ; Seeds/chemistry ; Spermatozoa ; Superoxide Dismutase/metabolism
Czasopismo naukowe
Tytuł:
Novel serratiopeptidase exhibits different affinities to the substrates and inhibitors.
Autorzy:
Hosseinzadeh SA; New Technologies Research Group, Nanobiotechnology Department, Pasteur Institute of Iran, Tehran, Iran.
Valizadeh V; New Technologies Research Group, Nanobiotechnology Department, Pasteur Institute of Iran, Tehran, Iran.
Rouhani M; New Technologies Research Group, Nanobiotechnology Department, Pasteur Institute of Iran, Tehran, Iran.; Department of Tissue Engineering and Applied Cell Science, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mirkazemi S; New Technologies Research Group, Nanobiotechnology Department, Pasteur Institute of Iran, Tehran, Iran.
Azizi M; Department of Molecular Medicine, Biotechnology Research center, Pasteur Institute of Iran, Tehran, Iran.
Norouzian D; New Technologies Research Group, Nanobiotechnology Department, Pasteur Institute of Iran, Tehran, Iran.
Ahangari Cohan R; New Technologies Research Group, Nanobiotechnology Department, Pasteur Institute of Iran, Tehran, Iran.
Pokaż więcej
Źródło:
Chemical biology & drug design [Chem Biol Drug Des] 2022 Oct; Vol. 100 (4), pp. 553-563. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article
MeSH Terms:
Bradykinin*
Caseins*
Anti-Inflammatory Agents ; Edetic Acid ; Hydrogen Bonding ; Hydrophobic and Hydrophilic Interactions ; Lisinopril ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Peptide Hydrolases
Czasopismo naukowe
Tytuł:
A rapid and sensitive ultra‐high‐performance liquid chromatography‐tandem mass spectrometry method for the simultaneous determination of atorvastatin calcium and lisinopril in rat plasma and its application in a pharmacokinetic study.
Autorzy:
Jia, Jirun (AUTHOR)
Bao, Rui (AUTHOR)
Hou, Jiayue (AUTHOR)
Qin, Mengdi (AUTHOR)
Li, Wen (AUTHOR)
Yang, Li (AUTHOR)
Fu, Qiang (AUTHOR)
Pokaż więcej
Źródło:
Separation Science Plus. Dec2023, Vol. 6 Issue 12, p1-8. 8p.
Czasopismo naukowe
Tytuł:
Evaluation of the clinical utility of the PromarkerD in-vitro test in predicting diabetic kidney disease and rapid renal decline through a conjoint analysis.
Autorzy:
Fusfeld L; Boston Healthcare Associates (now a Veranex Company), Boston, MA, United States of Ameria.
Murphy JT; Boston Healthcare Associates (now a Veranex Company), Boston, MA, United States of Ameria.
Yoon Y; Boston Healthcare Associates (now a Veranex Company), Boston, MA, United States of Ameria.
Kam LY; Proteomics International, Perth, Australia.
Peters KE; Proteomics International, Perth, Australia.
Lin Tan P; Proteomics International, Perth, Australia.
Shanik M; Stony Brook University Medical Center, Stony Brook, NY, United States of Ameria.; Endocrine Associates of Long Island, PC, Smithtown, NY, United States of Ameria.
Turchin A; Brigham and Women's Hospital, Boston, MA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Aug 01; Vol. 17 (8), pp. e0271740. Date of Electronic Publication: 2022 Aug 01 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetic Nephropathies*/etiology
Disease Progression ; Glomerular Filtration Rate ; Glycated Hemoglobin/analysis ; Humans ; Ibuprofen/therapeutic use ; Lisinopril
Czasopismo naukowe
Tytuł:
Expanding Synthetic Applications of Δ‐pyrroline‐2‐carboxylate Reductase from Pseudomonas syringae (DpkAPsyrin). Biocatalytic Asymmetric Synthesis of (S,E)‐2‐hydroxy‐4‐arylbut‐3‐enoic Acid Derivatives
Autorzy:
Moreno, Carlos J.
Gittings, Samantha
Schollmeyer, Dieter
Joglar, Jesús
Bujons, Jordi
Hernández, Karel
Clapés, Pere
Pokaż więcej
Temat:
PSEUDOMONAS syringae
ANGIOTENSIN converting enzyme
PSEUDOMONAS putida
ACID derivatives
ALDOL condensation
LISINOPRIL
Źródło:
Advanced Synthesis & Catalysis; 2/20/2024, Vol. 366 Issue 4, p990-1000, 11p
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies